Forbes

An increasing number of industry analysts say costs are under control for the likes of CVS Health, Centene, Cigna, Elevance Health, Humana, UnitedHealth Group and others.

A new generation of AI startups is emerging with powerful tools that could reshape how doctors work, make decisions, and ultimately deliver patient care.

A doctor breaks down what you need to know about rabies and how to stay safe amid the CDC new advisory on increased exposures.

A new two-step method makes more uniform antibody-drug conjugates by attaching cancer drugs at a precise antibody site, simplifying targeted cancer drug development.

On August 20, Kazakhstan's Elena Rybakina had to drop out of the Cincinnati Open with a left ankle injury. But now she's made it to the 2026 U.S. Open singles final.

A strong emergency plan does more than prepare for one scenario. Learn how families can build backup plans for communication, transportation, medical needs and care.

FDA-approved daraxonrasib targets RAS in metastatic pancreatic cancer, doubling median survival versus chemotherapy and delivering a long-awaited treatment advance.

Why calling OBBBA a “$1 trillion Medicaid cut” misses the bigger story: spending still rises, while the law trims a rapidly growing baseline.

Twenty-five years after 9/11, America’s public health preparedness gaps remain. Protecting the nation requires sustained investment before the next crisis.

With 28 million cosmetic procedures done in 2024, dermatology has never been more crowded. Here's how to separate proven treatments from hype.

NYT says Sen. Roger Marshall sued 700+ patients for unpaid OB-GYN bills. Patient harm is real—and so is the squeeze on independent practices.

Healthcare technology fragmented the patient experience. AI may help reconnect clinicians, medical information and patients while restoring the human side of care.

A public health expert explains how the Trump administration cancelling 16 minority health grants could adversely impact public health.

Startup Inspiren is using AI and sensors to keep residents in assisted living and memory care healthier and out of the ER.

Pharmacy benefit manager reforms through regulatory and legislative actions are weaker than promised. Furthermore, PBMs will likely adapt by finding new revenue streams.